Hiroshi Naka Selected Research

Hiroshi Naka Research Topics

6	Osteoporosis 09/2010 - 01/2002
4	Bone Resorption 02/2005 - 01/2002
3	Postmenopausal Osteoporosis 05/2020 - 01/2003
1	Hypoxia (Hypoxemia) 08/2020
1	Renal Insufficiency (Renal Failure) 05/2020
1	Dehydration (Water Stress) 01/2019
1	Dysgeusia (Parageusia) 12/2012
1	Frontotemporal Dementia (Semantic Dementia) 02/2012
1	Alzheimer Disease (Alzheimer's Disease) 02/2012
1	Motor Neuron Disease (Primary Lateral Sclerosis) 02/2012
1	Dementia (Dementias) 02/2012
1	Hypophosphatemia 10/2011
1	AIDS-Related Complex (ARC) 12/2008
1	Chronic Kidney Failure (Chronic Renal Failure) 02/2005
1	Osteitis 01/2004
1	Osteomalacia 01/2004

2	OsteocalcinIBA 02/2005 - 01/2003
2	deoxypyridinolineIBA 02/2005 - 01/2003
2	collagen type I trimeric cross-linked peptideIBA 02/2005 - 01/2004
2	Etidronic Acid (HEDP)FDA LinkGeneric 01/2004 - 01/2003
1	p38 Mitogen-Activated Protein KinasesIBA 08/2020
1	Phosphates (Orthophosphate)IBA 05/2020
1	Selective Estrogen Receptor Modulators (SERM)IBA 05/2020
1	bazedoxifeneIBA 05/2020
1	PalladiumIBA 01/2019
1	dichloroacetonitrileIBA 01/2019
1	NitrilesIBA 01/2019
1	AmidesIBA 01/2019
1	MicronutrientsIBA 12/2012
1	ZincIBA 12/2012
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 02/2012
1	Fibroblast Growth Factor-23IBA 10/2011
1	Raloxifene Hydrochloride (Evista)FDA Link 09/2010
1	tetrahydrofuranIBA 12/2008
1	CreatinineIBA 02/2005
1	Alkaline PhosphataseIBA 02/2005
1	Collagen Type I (Type I Collagen)IBA 02/2005
1	pyridinolineIBA 02/2005
1	Therapeutic UsesIBA 01/2004
1	Biomarkers (Surrogate Marker)IBA 01/2004
1	glutamyl- lysyl- alanyl- histidyl- aspartyl- glycyl- glycyl- arginineIBA 01/2004
1	Teriparatide (Parathar)FDA Link 01/2004
1	Indicators and Reagents (Reagents)IBA 01/2004
1	Aligeron (AS 2)IBA 01/2003
1	menatetrenoneIBA 01/2003
1	Vitamin K 2 (Vitamin K2)IBA 01/2003
1	IceIBA 01/2003
1	hydroxide ionIBA 01/2002
1	CalciumIBA 01/2002
1	alfacalcidolIBA 01/2002
1	Cholecalciferol (Vitamin D3)FDA Link 01/2002

1	Estrogen Replacement Therapy 01/2004
1	Subcutaneous Injections 01/2004
1	Oral Administration 01/2002